Minimally Invasive Surgery Market Analysis & Forecast- 2026-2033
Minimally Invasive Surgery Market size is estimated to be valued at USD 99,405.8 Mn in 2026 and is expected to reach USD 2,08,999.5 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033.
Key Takeaways
- By Device Type, The Surgical Devices Segment is projected to dominate the global minimally invasive surgery market outlook with a 56% share over the forecast period, owing to the rising demand for precision tools and advanced instrumentation in minimally invasive procedures.
- By Region, North America is expected to lead the market with a 43.2% share, driven by high adoption of robotic-assisted surgeries, strong healthcare infrastructure, and ongoing investments in surgical innovation.
Market Overview
The Minimally Invasive Surgery (MIS) market value is experiencing robust growth, driven by the increasing demand for procedures that offer reduced trauma, quicker recovery, and lower complication risks compared to traditional open surgeries. Usage of minimally invasive surgery for the treatment of major chronic diseases is expected to drive the global minimally invasive surgery market growth over the forecast period.
For instance, the adoption of minimally invasive transcatheter aortic valve replacement (TAVR) has significantly increased for patients with severe aortic stenosis. According to the American College of Cardiology, as of 2026, over 80% of eligible elderly patients in the U.S. are now treated with TAVR rather than open-heart surgery, owing to its advantages in minimizing postoperative complications and expediting recovery—highlighting a clear trend toward MIS in chronic disease management.
Current Events and Its Impact on the Minimally Invasive Surgery (MIS) Market
Event | Description and Impact |
EU Medical Device Regulations (MDR) Implementation |
|
FDA AI Integration for Regulatory Reviews |
|
Global Supply Chain Disruptions |
|
Segmental Insights

- Current Industry Events of 2026
- Market Size Estimation
- Regional Breakdown
- Competitive Landscape
- Customer Intelligence
- Segmental Analysis
- Pricing Analysis
- Key Market Drivers, Challenges & Future Trends
- Customized Insights Section
Minimally Invasive Surgery Market Insights, By Device Type
The surgical devices segment is expected to dominate with 56.0% share of the global minimally invasive surgery market over the forecast period. This segment includes ablation devices, electrosurgical devices, and medical robotic systems. The segment’s leading position is primarily driven by the growing use of endoscopy devices, which are integral to various minimally invasive procedures due to their ability to provide high-resolution imaging and precise navigation in confined anatomical areas. The expanding adoption of robotic-assisted surgical systems is further reinforcing the demand for advanced surgical tools, particularly in complex surgeries that require enhanced dexterity and precision.
Meanwhile, the monitoring & visualization devices and endoscopy devices segments are also poised for significant growth. These devices play a crucial role in enhancing procedural accuracy and minimizing intraoperative risks. Innovations in imaging technologies, such as 3D visualization and high-definition optics, are reshaping intraoperative guidance, making them indispensable tools for modern minimally invasive interventions.
Minimally Invasive Surgery Market Insights, By Surgery
Among surgical types, the cardiac surgery segment is expected to lead the global minimally invasive surgery market throughout the forecast period. This dominance is attributed to the rising global prevalence of cardiac disorders, which is fueling the demand for less invasive alternatives to conventional open-heart surgeries. Minimally invasive cardiac procedures offer the benefits of shorter recovery times, fewer complications, and reduced hospital stays, making them increasingly preferred by both patients and healthcare providers.
The orthopedic surgery segment is also projected to witness substantial growth over the coming years. The growing burden of musculoskeletal conditions, particularly osteoarthritis among the elderly population, is a key driver. For example, according to the World Health Organization, a significant portion of the global population aged 60 years and older suffers from osteoarthritis, contributing to a higher volume of joint replacement and repair procedures using minimally invasive techniques.
With the increasing application of MIS across other specialties such as gynecological, gastrointestinal, and cosmetic surgery, the surgery segment as a whole presents the highest potential to propel market growth, as healthcare systems increasingly prioritize procedures that reduce trauma and enhance patient outcomes.
Regional Insights

North America Minimally Invasive Surgery Market Analysis and Trends
North America is projected to dominate with 43.20% share of the global minimally invasive surgery market over the forecast period, supported by the region’s advanced healthcare infrastructure, strong adoption of innovative surgical technologies, and rising prevalence of chronic diseases—particularly cardiovascular conditions. The U.S., in particular, continues to lead in the use of robotic-assisted and image-guided minimally invasive procedures, driven by patient demand for faster recovery and lower procedural risks.
According to the New York State Department of Health (August 2026), approximately 697,000 people in the U.S. die from cardiac disease annually, underscoring a significant need for less invasive cardiac interventions. These high disease burdens, coupled with increasing investments in surgical innovation and training, are reinforcing North America’s leading position in the market. However, market growth in the region may be moderated by high procedural and device costs, as well as regulatory complexities.
Global Minimally Invasive Surgery: Market Dynamics
- Increasing Prevalence of Orthopedic Diseases
Increasing prevalence of orthopedic diseases is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in July 2022, according to World Health Organization (WHO), approximately 1.71 billion people have musculoskeletal conditions worldwide.
Global Minimally Invasive Surgery Market: Key Trends
- Increasing Number of Cardiac Surgeries
Increasing number of cardiac surgeries is expected to drive the global minimally invasive surgery market growth over the forecast period. For instance, in June 2022, according to an article published by National Institute of Health, more than 2 million people underwent open-heart surgery to treat various heart problems worldwide, every year.
Global Minimally Invasive Surgery Market: Restraint
- Disadvantages Associated with Minimally Invasive Surgery
Global minimally invasive surgery market growth can be hindered by disadvantages associated with minimally invasive surgery. For instance, according to Spine Institute of North America, a leading spine and pain specialist, the main disadvantage of minimally invasive surgery is that it requires a higher level of training, and thus, insufficient training can lead to complications such as perforation of the gallbladder, biliary leak, bile duct injury, biliary stricture, etc.
Hence, reducing the disadvantages associated with minimally invasive surgery will assess in the growth of the global minimally invasive surgery market.
Market Report Scope
Minimally Invasive Surgery Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 99,405.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.2% | 2033 Value Projection: | USD 2,08,999.5 Mn |
| Geographies covered: |
| ||
| Segments covered: |
| ||
| Companies covered: | Abbott, ArthroCare Corporation, Integer Holdings Corporation, Zimmer Biomet, DePuy Synthes, Inc., Conmed Corporation, GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., Biom’up SA, and Integrated Endoscopy | ||
| Growth Drivers: |
| ||
| Restraints & Challenges: |
| ||
Global Minimally Invasive Surgery Market- Cross Sectional Analysis
In surgery, cardiac surgery held a dominant segment in North America region due to increasing prevalence of cardiac disorders. For instance, in July 2020, according to Healthline Media LLC, a consumer health publisher, about 647,000 people die due to cardiac disease every year that makes it the leading cause of death in the U.S.
Analyst Viewpoint
- The global minimally invasive surgery (MIS) market is being propelled by the increasing burden of chronic diseases, notably cardiovascular and orthopedic conditions that require surgical intervention.
- Technological breakthroughs—particularly in robotic platforms, AI integration, and real-time imaging—are driving higher adoption by enhancing surgical precision and broadening the scope of treatable conditions.
- Strategic government programs, such as Horizon Europe and U.S. innovation grants, are accelerating surgical infrastructure upgrades and R&D investments in advanced MIS technologies.
- Barriers to growth include high capital costs of robotic systems, integration challenges within existing hospital workflows, and limited reimbursement schemes, especially in emerging regions.
- The steep learning curve for surgeons adopting complex MIS platforms continues to slow adoption rates in some settings.
- Outpatient surgical centers present a major growth opportunity, driven by rising patient preference for faster recovery and reduced hospital stays.
- Asia-Pacific is rapidly emerging as a high-growth region, supported by medical tourism, aging demographics, and increasing public-private investments in surgical modernization.
- The future of MIS will likely be shaped by nanotechnology, remote robotic surgeries, and AI-enabled procedural planning, with North America maintaining dominance through innovation and early technology integration.
Global Minimally Invasive Surgery Market- Key Developments
- In May 2025, Intuitive Surgical announced a next-generation upgrade to its da Vinci robotic system with enhanced tactile feedback and AI-assisted navigation, targeting complex thoracic and urologic procedures.
- In March 2025, CMR Surgical expanded the global rollout of its Versius robotic platform into Latin America and Southeast Asia, aiming to capture emerging market demand for compact, cost-effective MIS solutions.
- In February 2025, Johnson & Johnson’s Ethicon division received FDA clearance for its powered laparoscopic stapler with integrated real-time tissue sensing, improving precision and reducing intraoperative errors.
- In December 2024, the U.K.’s National Health Service (NHS) announced a strategic initiative to scale robotic-assisted surgeries from 70,000 to 500,000 annually by 2035, supported by additional public funding and training programs.
- In October 2024, Medtronic launched a VR-based surgical training suite in collaboration with major teaching hospitals in Europe to address the growing need for skilled MIS practitioners amid rapid technology adoption.
Market Segmentation
- Global Minimally Invasive Surgery Market, By Device Type (Revenue, USD Mn, 2021 - 2033)
- Surgical Devices
- Ablation Devices
- Electrosurgical Devices
- Medical Robotic Systems
- Monitoring & Visualization Devices
- Endoscopy Devices
- Surgical Devices
- Global Minimally Invasive Surgery Market, By Surgery (Revenue, USD Mn, 2021 - 2033)
- Orthopedic Surgery
- Cosmetic Surgery
- Breast Surgery
- Vascular Surgery
- Thoracic Surgery
- Gynecological Surgery
- Bariatric Surgery
- Cardiac Surgery
- Gastrointestinal Surgery
- Urological Surgery
- Global Minimally Invasive Surgery Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Abbott
- ArthroCare Corporation
- Integer Holdings Corporation
- Zimmer Biomet
- DePuy Synthes, Inc.
- Conmed Corporation
- GE Healthcare
- Given Imaging Ltd.
- Intuitive Surgical, Inc.
- Medtronic, plc.
- NuVasive, Inc.
- Philips Healthcare
- InMode Ltd.
- Titan Medical Inc.
- Fractyl Inc.
- Biom’up SA
- Integrated Endoscopy
Sources
Primary Research Interviews
- Leading MIS surgeons specializing in robotic-assisted procedures
- Medical device R&D heads from key market players
- Hospital administrators from AMC-ranked healthcare facilities
- Healthcare policy analysts from G20 nations
- Others
Databases
- WHO Global Health Observatory
- CMS Hospital Cost Report Information System
- OECD Health Statistics 2024
- Others
Magazines
- Medical Product Outsourcing Magazine
- Becker's Hospital Review
- The Surgeon's Journal
- Others
Journals
- Journal of Minimally Invasive Surgery
- Surgical Endoscopy
- Annals of Laparoscopic and Endoscopic Surgery
- Others
Newspapers
- Healthcare Business Today
- MedTech Dive
- The New England Journal of Medicine Catalyst
- Others
Associations
- Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)
- International Federation for the Surgery of Obesity (IFSO)
- American Association of Thoracic Surgery (AATS)
- Others
Public Domain Sources
- WHO Noncommunicable Diseases Progress Monitor 2025
- CDC National Hospital Discharge Survey
- European Commission Medical Device Regulation Portal
- Others
Proprietary Elements
- CMI Data Analytics Tool
- Proprietary CMI Existing Repository of Information for Last 8 Years
Get access to 250+ pages report
Every segment, forecast, competitor profile and data table behind the analysis above — available for instant download.
- ESOMAR Member
- ISO 9001:2015 Certified
- D-U-N-S Registered
- GDPR & CCPA Compliant
Missing comfort of reading report in your local language? Find your preferred language:
Transform your Strategy with Exclusive Trending Reports
Frequently Asked Questions
The Minimally Invasive Surgery Market size is estimated to be valued at USD 99,405.8 Mn in 2026, and is expected to reach USD 2,08,999.5 Mn by 2033.
The CAGR of the global Market is projected to be 11.2% from 2026 to 2033.
Increasing prevalence of orthopedic diseases is expected to drive the market growth.
Surgical devices is the leading device type segment in the market.
Disadvantages associated with minimally invasive surgery is expected to hinder the market growth over the forecast period.
Major players operating in the market include Abbott, ArthroCare Corporation, Integer Holdings Corporation, Zimmer Biomet, DePuy Synthes, Inc., Conmed Corporation, GE Healthcare, Given Imaging Ltd., Intuitive Surgical, Inc., Medtronic plc., NuVasive, Inc., Philips Healthcare, InMode Ltd., Titan Medical Inc., Fractyl Inc., Biom’up SA, Integrated Endoscopy
